Digital PCR for MRD detection of myeloma

Publisher:
Elsevier
Publication Type:
Conference Proceeding
Citation:
Clinical Lymphoma, Myeloma & Leukemia, 2015, 15 (Supplement 3), pp. E95 - E95 (1)
Issue Date:
2015-09
Full metadata record
Files in This Item:
Filename Description Size
Thumbnail15th-International-Myeloma-Wokshop.pdf Published version125.2 kB
Adobe PDF
A pilot study was performed to investigate the use of digital PCR (dPCR) to detect minimal residual disease (MRD) in patients with multiple myeloma. dPCR allows greater quantitative specificity in PCR reactions by performing multiple, minute PCR reactions on individual DNA templates.
Please use this identifier to cite or link to this item: